期刊文献+

高同型半胱氨酸血症与冠心病的关系 被引量:2

Relationship between hyperhomocysteinemia and coronary atherosclerotic cardiopathy
下载PDF
导出
摘要 目的探讨高同型半胱氨酸血症(HHCY)与冠心病(CHD)之间的关系。方法通过荧光偏振免疫分析试剂盒测定CHD患者及健康对照人群血同型半胱氨酸(HCY)的值进行比较。结果CHD组血HCY值为(18.63±4.16)μmol/L,明显高于健康对照组的(11.9±4.18)μmol/L(P<0.01)。结论HHCY与CHD发病关系密切,CHD患者HHCY广泛存在。 Objective To study relationship between hyperhomocysteinemia (HHCY) and coronary atherosclerotic cardiopathy ( CHD). Methods Comparing results of homocysteine ( HCY ) between group of CHD patients and group of controlled health people by fluorescent polarization immunizing analysis. Results The homocysteine value of the CHD patient group was ( 18.63 ± 4.16 ) μmol/ L,higher than controlled group ( 11.9 ±4. 18 ) μmol/L, with a signifcant difference between the two groups( P 〈0. 01 ). Conclusion HHCY has a close relation with CHD. HHCY extensively exists in the CHD patients.
出处 《滨州医学院学报》 2006年第2期99-100,共2页 Journal of Binzhou Medical University
关键词 高同型半胱氨酸血症 冠心病 hyperhomocysteinemia,coronary atherosclerotic cardiopathy
  • 相关文献

参考文献6

二级参考文献21

共引文献83

同被引文献27

  • 1范海荣,何青,孙福成,王抒,许锋,季福绥,夏永静.同型半胱氨酸水平与冠心病的关系[J].中华老年心脑血管病杂志,2004,6(4):223-225. 被引量:1
  • 2曹国良,乔永芳,俞建华,孙晓岚.轻中度高血压及合并冠心病患者血Hcy与颈动脉IMT的关系[J].中国新医药,2003,2(8):45-46. 被引量:4
  • 3刘传红,王玉桥,解青,洪英霞.冠心病患者血浆同型半胱氨酸水平的变化及护理干预的作用[J].郑州大学学报(医学版),2005,40(4):713-716. 被引量:1
  • 4the Joint International Society and Federation of Cardiology/World Health Organization. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation, 1979, 59: 607-609.
  • 5Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk fact or for vascular disease. Probable benefits of increasing folic acid intakes. JAMA, 1995. 274: 1049-1057.
  • 6Refsum H, Ueland PM, Nygerd O, et al. Homocysteine and cardiovascular disease. Annu Rev Med, 1998, 49: 31-62.
  • 7Verhoef P, Kok FJ, Kruyssen DA, et al. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol, 1997, 17(5): 989-995.
  • 8Evans RW, Shaten BJ, Hempel JD, et al. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol, 1997, 17(10): 1947-1953.
  • 9Verhoef P, Hennekens CH, Allen RH, et al. Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. Am J Cardiol, 1997, 79(6): 799-801.
  • 10Ford ES, Smith SJ, Stroup DF, et al. Homocysteine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol, 2002, 31: 59-70.

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部